CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Mga view
• 07/14/23
0
0
I-embed
administrator
Mga subscriber
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento